血液透析使用与实践模式:一项国际调查研究
该横断面调查由国际肾脏病学会于2018年7-9月召集182个国家利益相关者,最终160国(88%)代表参与。结果显示全球维持性血液透析使用中位数为298.4 pmp,新发肾衰竭患者透析使用中位数98.0 pmp,透析中心中位数4.5 pmp;充足透析服务、家庭透析、患者报告结局监测及血管通路使用在不同收入国家间差异显著,低收入国家患者自付比例更高。
要点
- 全球维持性血液透析使用中位数298.4 pmp,新发肾衰竭患者透析使用中位数98.0 pmp。
- 仅27%低收入国家普遍可提供充足透析服务,36%高收入国家普遍可提供家庭透析。
- 开始维持性透析时仅5%国家几乎所有患者使用动静脉通路,低收入国家患者自付费用更高。
核心结论
- 全球血液透析的使用、可获得性、可及性、质量和可负担性存在巨大差异,低收入和中低收入国家使用率最低。
研究设计与样本
- 横断面调查研究,由国际肾脏病学会于2018年7月至9月召集182个国家的利益相关者(临床医生、政策制定者和消费者代表),最终160个国家(88%)代表参与。
主要发现
- 全球维持性血液透析使用中位数为298.4 pmp(IQR 80.5-599.4),新发肾衰竭患者透析使用中位数98.0 pmp(IQR 81.5-140.8),透析中心中位数4.5 pmp(IQR 1.2-9.9)。
- 充足血液透析服务(每周3次、每次3-4小时)在27%的低收入国家普遍可提供,家庭血液透析在36%的高收入国家普遍可提供。
- 32%的国家监测患者报告结局,61%监测小分子清除率,60%监测骨矿物质标志物,51%监测技术生存率,60%监测患者生存率。
- 开始维持性透析时,仅5%的国家几乎所有患者使用动静脉通路;血管通路教育不理想,血管通路操作的资金支持不统一,低收入国家共付费用更高。
- 23%的低收入国家患者需支付超过75%的血液透析费用,而高收入国家仅4%的患者需支付如此比例。
临床怎么用
- 肾内科医生应关注不同收入水平地区血液透析可及性和可负担性的巨大差异,在资源有限地区优化透析服务提供和血管通路管理。
局限性
- 横断面调查可能存在应答偏倚和社会期望偏倚,数据收集有限,无法进行深入分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Hemodialysis (HD) is the most common form of kidney replacement therapy. This study aimed to examine the use, availability, accessibility, affordability, and quality of HD care worldwide. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders (clinicians, policy makers, and consumer representatives) in 182 countries were convened by the International Society of Nephrology from July to September 2018. OUTCOMES: Use, availability, accessibility, affordability, and quality of HD care. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Overall, representatives from 160 (88%) countries participated. Median country-specific use of maintenance HD was 298.4 (IQR, 80.5-599.4) per million population (pmp). Global median HD use among incident patients with kidney failure was 98.0 (IQR, 81.5-140.8) pmp and median number of HD centers was 4.5 (IQR, 1.2-9.9) pmp. Adequate HD services (3-4 hours 3 times weekly) were generally available in 27% of low-income countries. Home HD was generally available in 36% of high-income countries. 32% of countries performed monitoring of patient-reported outcomes; 61%, monitoring of small-solute clearance; 60%, monitoring of bone mineral markers; 51%, monitoring of technique survival; and 60%, monitoring of patient survival. At initiation of maintenance dialysis, only 5% of countries used an arteriovenous access in almost all patients. Vascular access education was suboptimal, funding for vascular access procedures was not uniform, and copayments were greater in countries with lower levels of income. Patients in 23% of the low-income countries had to pay >75% of HD costs compared with patients in only 4% of high-income countries. LIMITATIONS: A cross-sectional survey with possibility of response bias, social desirability bias, and limited data collection preventing in-depth analysis. CONCLUSIONS: In summary, findings reveal substantial variations in global HD use, availability, accessibility, quality, and affordability worldwide, with the lowest use evident in low- and lower-middle-income countries.
引用
- Htay H, Bello AK, Levin A, et al. Hemodialysis Use and Practice Patterns: An International Survey Study. Am J Kidney Dis. 2020. PMID: 32800843. doi:10.1053/j.ajkd.2020.05.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。